Jörn Markus Schattenberg (J M Schattenberg, Jorn Schattenberg, Joern M Schattenberg, Jörn M Schattenberg, Jörn Schattenberg)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 127

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

United European gastroenterology journal

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism 6 (6) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism 6 (6) (2024)
Shira Zelber-Sagi, Jörn Markus Schattenberg
Is curcumin the new kid on the block for the treatment of MASH? Hepatology (Baltimore, Md.) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism (2024)
Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn Markus Schattenberg
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study. Alimentary pharmacology & therapeutics 59 (10) (2024)
Susann Steffes, Karel Kostev, Jörn Markus Schattenberg, Hauke Sebastian Heinzow, Miriam Maschmeier
Elevated Colon Cancer Rates Linked to Prior Appendicitis: A Retrospective Cohort Study Based on Data from German General Practices. Journal of clinical medicine 13 (8) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn Markus Schattenberg
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study. Alimentary pharmacology & therapeutics 59 (10) (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism 6 (6) (2024)
Jörn Markus Schattenberg, Frank Tacke
Zeitschrift fur Gastroenterologie 62 (7) (2024)
Emma Vanderschueren, Angelo Armandi, Wilhelmus Josephus Kwanten, David Cassiman, Sven M Francque, Jörn Markus Schattenberg, Wim Laleman
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal (2024)
Susann Steffes, Karel Kostev, Jörn Markus Schattenberg, Hauke Sebastian Heinzow, Miriam Maschmeier
Elevated Colon Cancer Rates Linked to Prior Appendicitis: A Retrospective Cohort Study Based on Data from German General Practices. Journal of clinical medicine 13 (8) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn Markus Schattenberg
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study. Alimentary pharmacology & therapeutics (2024)
Emma Vanderschueren, Angelo Armandi, Wilhelmus Josephus Kwanten, David Cassiman, Sven M Francque, Jörn Markus Schattenberg, Wim Laleman
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease. The American journal of gastroenterology (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine 391 (4) (2024)
Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting, Trenton Ross, Barbara Bernardo, Anouk Oldenburger, Sara Toftegaard Hjuler, Iwona Ksiazek, Daniel Lindén, Detlef Schuppan, Sergio Rodriguez-Cuenca, Maria Manuela Tonini, Tamara R Castañeda, Aimo Kannt, Cecília Maria Pereira Rodrigues, Simon Cockell, Olivier Govaere, Ann K Daly, Michael E D Allison, Kristian Honnens de Lichtenberg, Yong Ook Kim, Anna Lindblom, Stephanie Oldham, Anne-Christine Andréasson, Franklin J Schlerman, Jonathon Marioneaux, Arun Sanyal, Marta B Afonso, Ramy Younes, Yuichiro Amano, Scott L Friedman, Shuang Wang, Dipankar Bhattacharya, Eric Simon, Valérie Paradis, Alastair Burt, Ioanna-Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Pors, Maja Worm Andersen, Michael Feigh, Carla Yunis, Pierre Bedossa, Michelle Stewart, Heather L Cater, Sara E Wells, Jörn Markus Schattenberg, Quentin Mark Anstee, null null, Dina Tiniakos, James W Perfield, Evangelia Petsalaki, Peter Davidsen, Antonio Vidal-Puig
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature metabolism (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine 391 (4) (2024)
Markus Schepers, Irene Schmidtmann, Daniela Zahn, Philipp Wild, Manfred Beutel, Alexander K Schuster, Thomas Münzel, Karl J Lackner, Katharina Geschke, Jörn Markus Schattenberg, Rieke Baumkötter, Simge Yilmaz, Daniel Wollschläger
Medical appointments and provision of medical care during the COVID-19 pandemic in Mainz, Germany. PloS one 18 (1) (2023)
Joost Boeckmans, Jörn Markus Schattenberg
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: insights from the UK Biobank. Liver international : official journal of the International Association for the Study of the Liver (2023)
Philip Noel Newsome, Arun J Sanyal, Guy Neff, Jörn Markus Schattenberg, Vlad Ratziu, Judith Ertle, Jasmin Link, Alison Mackie, Corinna Schoelch, Eric Lawitz, null null
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis. Nature communications 14 (1) (2023)
Johanna Schönau, Axel Wester, Hannes Hagström, Jörn Markus Schattenberg
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis. Journal of internal medicine (2023)
Angelo Armandi, Talal Merizian, Merle Marie Werner, Harvey O Coxson, Tiziana Sanavia, Giovanni Birolo, Isabella Gashaw, Judith Ertle, Maurice Michel, Peter R Galle, Christian Labenz, Tilman Emrich, Jörn Markus Schattenberg
Variability of transient elastography-based spleen stiffness performed at 100 Hz. European radiology experimental 7 (1) (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology (2023)
Markus Schepers, Irene Schmidtmann, Daniela Zahn, Philipp Wild, Manfred Beutel, Alexander K Schuster, Thomas Münzel, Karl J Lackner, Katharina Geschke, Jörn Markus Schattenberg, Rieke Baumkötter, Simge Yilmaz, Daniel Wollschläger
Medical appointments and provision of medical care during the COVID-19 pandemic in Mainz, Germany. PloS one 18 (1) (2023)
Kris V Kowdley, Christopher L Bowlus, Cynthia Levy, Ulus S Akarca, Mario Reis Alvares-da-Silva, Pietro Andreone, Marco Arrese, Christophe Corpechot, Sven M Francque, Michael A Heneghan, Pietro Invernizzi, David Jones, Frederik C Kruger, Eric Lawitz, Marlyn J Mayo, Mitchell L Shiffman, Mark G Swain, José Miguel Valera, Victor Vargas, John M Vierling, Alejandra Villamil, Carol Addy, Julie Dietrich, Jean-Michel Germain, Sarah Mazain, Dragutin Rafailovic, Bachirou Taddé, Benjamin Miller, Jianfen Shu, Claudia O Zein, Jörn Markus Schattenberg, null null
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. The New England journal of medicine (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology 97 (6) (2023)
Markus Schepers, Irene Schmidtmann, Daniela Zahn, Philipp Wild, Manfred Beutel, Alexander K Schuster, Thomas Münzel, Karl J Lackner, Katharina Geschke, Jörn Markus Schattenberg, Rieke Baumkötter, Simge Yilmaz, Daniel Wollschläger
Medical appointments and provision of medical care during the COVID-19 pandemic in Mainz, Germany. PloS one 18 (1) (2023)
Arunkumar Krishnan, Carolin V Schneider, Jörn Markus Schattenberg, Saleh A Alqahthani
Risk of severe disease and mortality of COVID-19 in patients with Budd-Chiari syndrome: A population-based matched cohort study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Markus Schepers, Irene Schmidtmann, Daniela Zahn, Philipp Wild, Manfred Beutel, Alexander K Schuster, Thomas Münzel, Karl J Lackner, Katharina Geschke, Jörn Markus Schattenberg, Rieke Baumkötter, Simge Yilmaz, Daniel Wollschläger
Medical appointments and provision of medical care during the COVID-19 pandemic in Mainz, Germany. PloS one 18 (1) (2023)
Joost Boeckmans, Jörn Markus Schattenberg
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank. Liver international : official journal of the International Association for the Study of the Liver (2023)
Olivier Govaere, Megan S R Hasoon, Leigh Alexander, Simon J Cockell, Dina Tiniakos, Mattias Ekstedt, Jörn Markus Schattenberg, Jerome Boursier, Elisabetta Bugianesi, Vlad Ratziu, null null, Ann K Daly, Quentin Mark Anstee
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nature metabolism (2023)
Stephen A Harrison, Vlad Ratziu, Quentin Mark Anstee, Mazen Noureddin, Arun J Sanyal, Jörn Markus Schattenberg, Pierre Bedossa, Mustafa R Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V Kowdley, Zobair M Younossi, Rohit Loomba
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Arunkumar Krishnan, Carolin V Schneider, Jörn Markus Schattenberg, Saleh A Alqahthani
Research Letters: Risk of severe disease and mortality of COVID-19 in patients with Budd-Chiari syndrome: A Population-Based Matched Cohort Study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology 97 (6) (2023)
Jeffrey Victor Lazarus, Hannah Han, Henry E Mark, Saleh A Alqahtani, Jörn Markus Schattenberg, Joan B Soriano, Trenton M White, Shira Zelber-Sagi, M Ashworth Dirac, null null
The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories. Hepatology (Baltimore, Md.) 78 (3) (2023)
Maurice Michel, Jörn Markus Schattenberg
Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations? Alimentary pharmacology & therapeutics 59 (2) (2023)
Maurice Michel, Jörn Markus Schattenberg
Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations? Alimentary pharmacology & therapeutics 59 (2) (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim Marcelino Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Johanna Schönau, Axel Wester, Jörn Markus Schattenberg, Hannes Hagström
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study. Journal of internal medicine (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim M Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis. A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Johanna Schönau, Axel Wester, Jörn Markus Schattenberg, Hannes Hagström
Risk of fractures and post-fracture mortality in 3,980 people with Primary Biliary Cholangitis: A population-based cohort study. Journal of internal medicine (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim Marcelino Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Simon Johannes Gairing, Eva M Schleicher, Leonard Kaps, Sophia Schulte-Beerbuehl, Kristina Steiner, Christian Labenz, Jörn Markus Schattenberg, Peter R Galle, Marcus-Alexander Wörns, Christian Labenz
Development and evaluation of a virtual reality driving test for patients with cirrhosis. Hepatology communications 7 (11) (2023)
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, Jörn Markus Schattenberg
Liver stiffness as a cornerstone in heart disease risk assessment. Liver international : official journal of the International Association for the Study of the Liver (2023)
Andreas Teufel, Andreas Geier, Christoph Sarrazin, Jörn Markus Schattenberg, Achim Kautz, Rebecca Dorner, Jan Kramer, Katrin Jerysiak, Theodor Baars, Bastian Hönscheid, Dirk Müller-Wieland, Siegbert Rossol, Christian Trautwein, Frank Tacke, Peter Lemmer
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)]. Zeitschrift fur Gastroenterologie (2023)
Markus Schepers, Irene Schmidtmann, Daniela Zahn, Philipp Wild, Manfred Beutel, Alexander K Schuster, Thomas Münzel, Karl J Lackner, Katharina Geschke, Jörn Markus Schattenberg, Rieke Baumkötter, Simge Yilmaz, Daniel Wollschläger
Medical appointments and provision of medical care during the COVID-19 pandemic in Mainz, Germany. PloS one 18 (1) (2023)
Martin Franck, Katharina John, Sherin Al Aoua, Monika Rau, Andreas Geier, Jörn Markus Schattenberg, Heiner Wedemeyer, Klaus Schulze-Osthoff, Heike Bantel
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Ger H Koek, Robim Marcelino Rodrigues, Tamara Vanhaecke
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver international : official journal of the International Association for the Study of the Liver (2023)
Joost Boeckmans, Alexandra Gatzios, Jörn Markus Schattenberg, Robim Marcelino Rodrigues, Vera Rogiers, Tamara Vanhaecke
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities. Archives of toxicology 97 (6) (2023)
Omar Hahad, Volker H Schmitt, Natalie Arnold, Karsten Keller, Jürgen H Prochaska, Philipp S Wild, Andreas Schulz, Karl J Lackner, Norbert Pfeiffer, Irene Schmidtmann, Matthias Michal, Jörn Markus Schattenberg, Oliver Tüscher, Andreas Daiber, Thomas Münzel
Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort. Clinical research in cardiology : official journal of the German Cardiac Society (2022)
Dirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Tiemo Sven Gerber, Bruno Christian Köhler, Federico Nichetti, Annekathrin Ludt, Nadine Gehrke, Jörn Markus Schattenberg, Stefan Heinrich, Wilfried Roth, Beate Katharina Straub
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome. Cancers 14 (2) (2022)
Maurice Michel, Alisha Wahl, Malena Anders, Saleh A Alqahtani, Wolfgang M Kremer, Peter R Galle, Christian Labenz, Daniel Grimm, Martin Sprinzl, Jörn Markus Schattenberg
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2022)
Nadine Gehrke, Marcus A Wörns, Amrit Mann, Nadine Hövelmeyer, Esther Von Stebut, Beate K Straub, Peter R Galle, Jörn Markus Schattenberg
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure. Cell death & disease 13 (5) (2022)
Eva Maria Schleicher, Simon Johannes Gairing, Peter Robert Galle, Julia Weinmann-Menke, Jörn Markus Schattenberg, Karel Kostev, Christian Labenz
A higher FIB-4 index is associated with an increased incidence of renal failure in the general population. Hepatology communications 6 (12) (2022)
Nadine Gehrke, Lea J Hofmann, Beate K Straub, Frank Rühle, Ari Waisman, Peter R Galle, Jörn Markus Schattenberg
Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease. Clinical and translational medicine 12 (9) (2022)
Simon Johannes Gairing, Julian Anders, Leonard Kaps, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter Robert Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Christian Labenz
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology communications 6 (5) (2022)
Vlad Ratziu, Quentin Mark Anstee, Vincent Wai-Sun Wong, Jörn Markus Schattenberg, Elisabetta Bugianesi, Salvador Augustin, Liana Gheorghe, Vittoria Zambon, Nancy S Reau
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. Hepatology (Baltimore, Md.) 76 (6) (2022)
Leonard Kaps, Lejla Lukac, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Simon Johannes Gairing, Peter Robert Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Maurice Michel, Christian Labenz, Malena Anders, Alisha Wahl, Lisann Girolstein, Leonard Kaps, Wolfgang M Kremer, Yvonne Huber, Peter R Galle, Martin Sprinzl, Jörn Markus Schattenberg
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIV. Hepatology communications 6 (8) (2022)
Simon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, Christian Labenz, Felix Darstein, Daniel Grimm, Visvakanth Sivanathan, Arndt Weinmann, Marcus-Alexander Wörns, Roman Kloeckner, Michael B Pitton, Florian Thieringer, Khan Fareed Rahman, Peter Robert Galle, Jörn Markus Schattenberg, Friedrich Förster
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case report. Zeitschrift fur Gastroenterologie (2022)
Katharina John, Martin Franck, Sherin Al Aoua, Monika Rau, Yvonne Huber, Jörn Markus Schattenberg, Andreas Geier, Matthias J Bahr, Heiner Wedemeyer, Klaus Schulze-Osthoff, Heike Bantel
Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4. Journal of clinical medicine 11 (15) (2022)
Simon Johannes Gairing, Jörn Markus Schattenberg
The unmet need of personalized HCC screening-Lessons learned from the Swedish nationwide registries. United European gastroenterology journal 10 (5) (2022)
Yvonne Huber, Andreas Schulz, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Peter R Galle, Philipp S Wild, Karl J Lackner, Jörn Markus Schattenberg
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in Germany. Hepatology communications 6 (6) (2022)
Jeffrey Victor Lazarus, Henry E Mark, Massimo G Colombo, Alessandro Rhyl Demaio, John F Dillon, Jacob George, Hannes Hagström, Samantha L Hocking, Nancy Lee, Mark J Nieuwenhuijsen, Mary E Rinella, Manuel Romero, Joan B Soriano, Jörn Markus Schattenberg, Frank Tacke, Emmanuel A Tsochatzis, Luca Vittorio Valenti, Shira Zelber-Sagi, M Ashworth Dirac, Terry T K Huang
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. Alimentary pharmacology & therapeutics (2021)
Jeffrey Victor Lazarus, Quentin Mark Anstee, Hannes Hagström, Kenneth Cusi, Helena Cortez-Pinto, Henry E Mark, Michael Roden, Emmanuel A Tsochatzis, Vincent Wai-Sun Wong, Zobair M Younossi, Shira Zelber-Sagi, Manuel Romero, Jörn Markus Schattenberg
Defining comprehensive models of care for NAFLD. Nature reviews. Gastroenterology & hepatology 18 (10) (2021)
Olivier Govaere, Simon J Cockell, Dina Tiniakos, Rachel Queen, Ramy Younes, Michele Vacca, Leigh Alexander, Federico Ravaioli, Jeremy Palmer, Salvatore Petta, Jerome Boursier, Chiara Rosso, Katherine Johnson, Kristy Wonders, Christopher P Day, Mattias Ekstedt, Matej Oresic, Rebecca Darlay, Heather J Cordell, Fabio Marra, Antonio Vidal-Puig, Pierre Bedossa, Jörn Markus Schattenberg, Karine Clement, Michael E D Allison, Elisabetta Bugianesi, Vlad Ratziu, Ann K Daly, Quentin Mark Anstee
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Science translational medicine 12 (572) (2021)
Pere Ginès, Laurent Castera, Frank Lammert, Isabel Graupera, Miquel Serra-Burriel, Alina M Allen, Vincent Wai-Sun Wong, Phillipp Hartmann, Maja Thiele, Llorenç Caballeria, Robert J de Knegt, Ivica Grgurevic, Salvador Augustin, Emmanuel A Tsochatzis, Jörn Markus Schattenberg, Indra Neil Guha, Andrea Martini, Rosa M Morillas, Montserrat Garcia-Retortillo, Harry de Koning, Núria Fabrellas Padrés, Judit Pich, Ann T Ma, M Alba Diaz, Dominique Roulot, Philip Noel Newsome, Michael Manns, Patrick S Kamath, Aleksander Krag, null null
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology (Baltimore, Md.) (2021)
Saleh A Alqahtani, Jörn Markus Schattenberg
Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice. Expert review of molecular diagnostics 21 (10) (2021)
Christian Labenz, Jörn Markus Schattenberg
Letter: proton pump inhibitor use and bone fracture risk-a mechanistic point of view. Authors' reply. Alimentary pharmacology & therapeutics 53 (5) (2021)
Maurice Michel, Francesca Spinelli, Annette Grambihler, Christian Labenz, Michael Nagel, Leonard Kaps, Yvonne Huber, Peter R Galle, Marcus-Alexander Wörns, Jörn Markus Schattenberg
Health-related quality of life in patients with autoimmune hepatitis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 30 (10) (2021)
Anne-Marieke Van Dijk, Jörn Markus Schattenberg, Adriaan G Holleboom, Maarten E Tushuizen
Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease. United European gastroenterology journal 9 (8) (2021)
Simon Johannes Gairing, Peter Robert Galle, Jörn Markus Schattenberg, Karel Kostev, Christian Labenz
Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders. Journal of clinical medicine 10 (23) (2021)
Angelo Armandi, Jörn Markus Schattenberg
Editorial: the polygenic risk of cirrhosis development. Alimentary pharmacology & therapeutics 53 (7) (2021)
Sven M Francque, Pierre Bedossa, Vlad Ratziu, Quentin M Anstee, Elisabetta Bugianesi, Arun J Sanyal, Rohit Loomba, Stephen A Harrison, Rozalina Balabanska, Lyudmila Mateva, Nicolas Lanthier, Naim Alkhouri, Christophe Moreno, Jörn Markus Schattenberg, Diana Stefanova-Petrova, Luisa Vonghia, Régine Rouzier, Maeva Guillaume, Alexander Hodge, Manuel Romero-Gómez, Philippe Huot-Marchand, Martine Baudin, Marie-Paule Richard, Jean-Louis Abitbol, Pierre Broqua, Jean-Louis Junien, Manal F Abdelmalek, null null
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. The New England journal of medicine 385 (17) (2021)
Jeffrey Victor Lazarus, Henry E Mark, Quentin Mark Anstee, Juan Pablo Arab, Rachel L Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven M Francque, Jacob George, Hannes Hagström, Terry T K Huang, Mona H Ismail, Achim Kautz, Shiv Kumar Sarin, Stephen Caldwell, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero, Jörn Markus Schattenberg, Emmanuel A Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi, null null
Advancing the global public health agenda for NAFLD: a consensus statement. Nature reviews. Gastroenterology & hepatology (2021)
Hannes Hagström, Leon A Adams, Alina M Allen, Christopher D Byrne, Yoosoo Chang, Henning Grønbæk, Mona Ismail, Peter Jepsen, Fasiha Kanwal, Jennifer R Kramer, Jeffrey Victor Lazarus, Michelle T Long, Rohit Loomba, Philip Noel Newsome, Denis Moir, Seungho Ryu, Jörn Markus Schattenberg, Marina Serper, Nick Sheron, Tracey G Simon, Elliot B Tapper, Sarah Wild, Vincent Wai-Sun Wong, Yusuf Yilmaz, Shira Zelber-Sagi, Fredrik O Åberg
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology (Baltimore, Md.) 74 (1) (2021)
Jörn Markus Schattenberg, Jeffrey Victor Lazarus, Philip N Newsome, Lawrence Serfaty, Alessio Aghemo, Salvador Augustin, Emmanuel A Tsochatzis, Victor De Ledinghen, Elisabetta Bugianesi, Manuel Romero, Heike Bantel, Stephen D Ryder, Jerome Boursier, Vincent Leroy, Javier Crespo, Laurent Castera, Lefteris Floros, Vincenzo Atella, Jorge Mestre-Ferrandiz, Rachel Elliott, Achim Kautz, Alice Morgan, Sally Hartmanis, Sharad Vasudevan, Lynne Pezzullo, Aldo Trylesinski, Sandrine Cure, Victoria Higgins, Vlad Ratziu
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Anne Linde Mak, Jenny Lee, Anne-Marieke Van Dijk, Yasaman Vali, Guruprasad P Aithal, Jörn Markus Schattenberg, Quentin Mark Anstee, M Julia Brosnan, Mohammad Hadi Zafarmand, Dewkoemar Ramsoekh, Stephen A Harrison, Max Nieuwdorp, Patrick M Bossuyt, Adriaan G Holleboom
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 9 (12) (2021)
Saleh A Alqahthani, Jörn Markus Schattenberg
NAFLD in the Elderly. Clinical interventions in aging 16 (2021)
Simon J Gairing, Roman Kloeckner, Michael B Pitton, Janine Baumgart, Charis von Auer-Wegener, Hauke Lang, Peter R Galle, Friedrich Foerster, Jörn Markus Schattenberg
Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion. Zeitschrift fur Gastroenterologie 59 (1) (2021)
Leonard Kaps, C J Ahlbrand, R Gadban, M Nagel, C Labenz, P Klimpke, S Holtz, S Boedecker, M Michel, W M Kremer, M Hilscher, P R Galle, D Kraus, Jörn Markus Schattenberg, Julia Weinmann-Menke
Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care. PloS one 16 (4) (2021)
Christian Labenz, Karel Kostev, Angelo Armandi, Peter R Galle, Jörn Markus Schattenberg
Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany. United European gastroenterology journal (2021)
Jörn Markus Schattenberg, Quentin M Anstee, Cyrielle Caussy, Elisabetta Bugianesi, Branko Popovic
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. Expert review of gastroenterology & hepatology 15 (11) (2021)
Angelo Armandi, Jörn Markus Schattenberg
Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches. Nutrients 13 (6) (2021)
Leonard Kaps, Katharina Hildebrand, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter R Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Christian Labenz
Risk factors for poorer health literacy in patients with liver cirrhosis. PloS one 16 (7) (2021)
Tilman Emrich, Jörn Markus Schattenberg
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing. Alimentary pharmacology & therapeutics 54 (2) (2021)
Leonardo Ruiz-Casas, Sonia O'Hara, Claudia Mighiu, Alan Finnegan, Alison Taylor, Emily Ventura, Anil Dhawan, Karen F Murray, Jörn Markus Schattenberg, Jose Willemse, Melanie Karakaidos, Harpreet Brrang
Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study. Expert review of pharmacoeconomics & outcomes research 21 (2) (2021)
Katharina Bahr, Perikles Simon, Barbara Leggewie, Haralampos Gouveris, Jörn Markus Schattenberg
The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome. Biology 11 (1) (2021)
Christian Labenz, Karel Kostev, Leonard Kaps, Peter R Galle, Jörn Markus Schattenberg
Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany. Digestive diseases and sciences 66 (9) (2020)
Jörn Markus Schattenberg
Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH). Expert opinion on investigational drugs 29 (2) (2020)
Leonard Kaps, Christian Labenz, Peter R Galle, Julia Weinmann-Menke, Karel Kostev, Jörn Markus Schattenberg
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. United European gastroenterology journal 8 (8) (2020)

Jörn Markus Schattenberg.css-eqlu8i{font-size:small;padding-left:4px;} (J M Schattenberg, Jorn Schattenberg, Joern M Schattenberg, Jörn M Schattenberg, Jörn Schattenberg)

Publication Activity (10 Years)

Top Topics

Top Venues

Jörn Markus Schattenberg (J M Schattenberg, Jorn Schattenberg, Joern M Schattenberg, Jörn M Schattenberg, Jörn Schattenberg)